ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2023. The put-call ratio across all filers is 16.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $21,494 | +480.1% | 4,787 | +114.5% | 0.00% | – |
| Q4 2023 | $3,705 | +85.1% | 2,232 | 0.0% | 0.00% | – |
| Q3 2023 | $2,002 | +881.4% | 2,232 | +2249.5% | 0.00% | – |
| Q2 2023 | $204 | +10.3% | 95 | 0.0% | 0.00% | – |
| Q1 2023 | $185 | -94.6% | 95 | -89.4% | 0.00% | – |
| Q4 2022 | $3,456 | -13.6% | 900 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 900 | +800.0% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 100 | -50.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -61.5% | 200 | -50.0% | 0.00% | – |
| Q4 2020 | $13,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 11,167,800 | $24,010,770 | 3.60% |
| Sio Capital Management, LLC | 4,020,705 | $8,644,516 | 2.20% |
| Redmile Group, LLC | 14,049,935 | $30,207,360 | 1.16% |
| Vantage Consulting Group Inc | 885,520 | $1,903,868 | 1.10% |
| Blue Owl Capital Holdings LP | 733,568 | $1,577,171 | 0.97% |
| AlphaCentric Advisors LLC | 778,000 | $1,672,700 | 0.93% |
| Affinity Asset Advisors, LLC | 600,000 | $1,290,000 | 0.45% |
| GCM Grosvenor Holdings, LLC | 410,888 | $883,409 | 0.38% |
| Indie Asset Partners, LLC | 93,839 | $201,754 | 0.22% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $3,541,115 | 0.21% |